SREBF1 and metabolic dysfunction-associated steatotic liver disease: The same year, Chen et al. found that upregulation of NEAT1 inactivates the AMPK/SREBP-1 signaling pathway by sponging miR-146a, thus liberating the expression of ROCK1, promoting NAFLD progression through hepatic lipid accumulation [217].